0001209191-23-058861.txt : 20231215 0001209191-23-058861.hdr.sgml : 20231215 20231215180707 ACCESSION NUMBER: 0001209191-23-058861 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231213 FILED AS OF DATE: 20231215 DATE AS OF CHANGE: 20231215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zalevsky Jonathan CENTRAL INDEX KEY: 0001789857 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24006 FILM NUMBER: 231491705 MAIL ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH STREET 2: C/O NEKTAR THERAPEUTICS CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEKTAR THERAPEUTICS CENTRAL INDEX KEY: 0000906709 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943134940 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 4154825300 MAIL ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 FORMER COMPANY: FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS INC DATE OF NAME CHANGE: 19980723 FORMER COMPANY: FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS DATE OF NAME CHANGE: 19940303 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-12-13 0 0000906709 NEKTAR THERAPEUTICS NKTR 0001789857 Zalevsky Jonathan C/O NEKTAR THERAPEUTICS 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 0 1 0 0 Chief R&D Officer 0 Stock Option 0.50 2023-12-13 4 A 0 250000 0.00 A 2031-12-12 Common Stock 250000 250000 D This stock option vests over three years from the date of grant, (December 13, 2023) in equal monthly installments based on continued service. Mark A. Wilson, Attorney-in-Fact 2023-12-15